fbpx
A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Start earning CE Units in minutes!


Course Library New User Existing User Help

A Novel Approach to Treating Retrograde Peri-Implantitis

Current Status
Not Enrolled
Price
$22.00
Get Started

The early diagnosis and treatment of these rare lesions will improve patient satisfaction and implant maintenance.

AGD Subject Code: 490

Educational ­Objectives

After reading this course, the participant should be able to:

  1. Identify the clinical and radiographic characteristics of retrograde peri-implantitis (RPI) and understand its potential etiological factors.
  2. Discuss treatment options for RPI based on the clinical and radiographic presentation.
  3. Assess the potential role of recombinant human platelet derived growth factor (rh-PDGF) in combination with bone allograft materials for the treatment of RPI.

This course was published in the April/May 2024 issue and expires May 2027. The authors have no commercial conflicts of interest to disclose. This 2 credit hour self-study activity is electronically mediated.


Belmont Business Media is an ADA CERP-recognized provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ada.org/cerp. Belmont Business Media Nationally Approved PACE Program Provider for FAGD/MAGD credit. Approval does not imply acceptance by any regulatory authority or AGD endorsement. 7/1/2023 to 6/30/2026. Provider ID 317924
3621 Harbor Blvd., Suite 265, Santa Ana, CA 92704

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy